NEW DELHI:
Serum Institute of India (
SII) has urged the government to take up inclusion of
Covishield in the EU Covid-19 Vaccination Passport with the
European Union and other countries, saying if not done it will affect students and business travellers, and disrupt the Indian and global economy. Only four vaccines Comirnaty of Pfizer/BioNTech,
Moderna, Vaxzervria by AstraZeneca-Oxford and, Johnson & Johnson's Janssen have been approved by the
European Medicines Agency (EMA). Only those inoculated with these vaccines will be given vaccination passports and allowed to travel within the EU during the pandemic.
"India has a large population. However, not including Covishield in the EU Covid-19 Vaccination Passport will not allow Covishield vaccinated people to travel to European countries and this will affect students, business travellers back and forth, and cause severe disruptions to our economy and to the global economy," a source quoted Adar C Poonawalla, CEO of SII, as having communicated in a letter to external affairs minister S Jaishankar.
Sources said referring to Poonawalla's letter, the director of government and regulatory affairs at SII,
Prakash Kumar Singh, has also sought Jaishankar's intervention at the highest level.